2001, Compliance, COVID-19 and Licensing - Health Care Compliance Brief

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2001

Compliance

COVID-19

Licensing

SQA Regulatory Surveillance Summary | Monthly Update 2022 – June

SQA

SEPTEMBER 2, 2022

ANVISA published the RDC 702/2022, which repeals some requirements that were instituted to speed market approval of devices needed to treat patients during the height of the COVID-19 pandemic. The Agency recently published the first list of critical medicines for the management of the COVID-19 pandemic.

FDA

FDA COVID-19 Nursing Homes Compliance

SQA Regulatory Surveillance Summary | Monthly Update 2022 – September/October

SQA

DECEMBER 16, 2022

ANVISA announced major updates to its Resolution of the Collegiate Board of Directors (RDC) 185/2001. China’s Center for Medical Device Evaluation (CMDE) Update Compliance Guidelines and Recommended Paths for Clinical Evaluation Paths for Certain Medical Devices, 25 July 2022. 19 Medical Rehabilitation Equipment.

FDA

FDA Compliance COVID-19 Licensing

SQA Regulatory Surveillance Summary | Monthly Update 2022 – June

SQA Regulatory Surveillance Summary | Monthly Update 2022 – September/October

Stay Connected